About Theron Pharma
Theron Pharma is a Healthcare company based in Sunnyvale (United States) founded in 2008. Specialty drugs for chronic respiratory diseases are developed. Theron Pharma has raised $2.21 million across 6 funding rounds from investors including HHS. Its focus areas include Life Sciences, Pulmonology, Drugs and COPD and Asthma. Its legal entity is Theron Pharmaceuticals Inc. Its competitors include Dren Bio, PureTech Health and Innoviva; 2 of its 3 listed competitors have raised funding.
Company details
Theron Pharma was founded in 2008 in Sunnyvale, United States, within the pharmaceutical sector. Long-acting M3 muscarinic antagonists are developed for treating chronic obstructive pulmonary disease and severe asthma. Focus is placed on a once-daily inhaled bronchodilator with properties enabling use across dry powder inhalers, metered-dose inhalers, and nebulizers, alongside compatibility for multi-drug formulations. Operations center on drug development for respiratory conditions.
- Headquarters Sunnyvale, United States
- SectorsHealthcare
- Website theronpharma.com
- Social LinkedIn
- Legal Name Theron Pharmaceuticals Inc
- Total Equity Funding$2.21M (USD)
in 6 rounds
- Latest Funding Round$409.1K (USD), Seed
Jul 2015
- Investors
Funding Insights of Theron Pharma
Theron Pharma has successfully raised a total of $2.21M across 6 strategic funding rounds. The most recent funding activity was a Seed round of $409.1 thousand completed in July 2015. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $2.21M
- Total Rounds 6
- Last Round Seed — $409,099
- First Round $180,000
(May 2009)
- Investors Count 1
All 6 funding rounds of Theron Pharma with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
1 investors in total: 1 institutional.
Investors in Theron Pharma
Theron Pharma has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include HHS.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Public health and human services are overseen by HHS. | 1953 | hhs.gov |
Investor details for Theron Pharma
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Theron Pharma
7 people are tracked at Theron Pharma (3 in leadership, 4 in board & advisors).
| Name | Role | Group |
|---|---|---|
Xiaoming Zhang | Co-Founder | Leadership |
Jürg Pfister | Co-Founder | Leadership |
M. Venkatraman | Co-Founder | Leadership |
Terry Porter | Advisor | Board & advisors |
Allan Kramer | Director | Board & advisors |
Cary Queen | Director | Board & advisors |
James Larrick | Chairman | Board & advisors |
Complete people profiles for Theron Pharma
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Theron Pharma
3 dated milestones of Theron Pharma across 7 years, from founding to its latest funding, stage changes and deals.
- Founded Theron Pharma is founded.
- Funding First funding round of $180K.
- Funding Latest funding round, Seed, of $409K.
Competitors of Theron Pharma
Theron Pharma has 3 listed competitors in our database, 2 of them funded. They include Dren Bio, PureTech Health and Innoviva.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| drenbio.com | 2019 | San Carlos, United States | $131M | Therapeutic antibodies are developed for cancer, autoimmune, and serious diseases. | ||
| puretechhealth.com | 2001 | Boston, United States | $107M | 171 | Immunotherapeutics are developed for inflammation, fibrosis, and lung diseases. | |
| inva.com | 1996 | Brisbane, United States | 101 | Respiratory prescription drugs are developed and in-licensed for COPD treatment. |
Detailed competitors of Theron Pharma
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Immunology & Cancer Therapeutics
3 companies that operate in the same segment as Theron Pharma (Immunology & Cancer Therapeutics) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Targeted and immune-oncology drugs for cancer treatment are developed. | 2010 | Cambridge, Massachusetts, United States | USD 172 M | |||
Immuno-modulatory therapies for dementia and neurodegenerative disorders are developed. | 2013 | San Francisco, California, United States | USD 214.78 M | USD 21.05 M | 211 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Theron Pharma
Theron Pharma was founded in 2008 and raised its 1st funding round 1 year after it was founded.
Theron Pharma is headquartered in Sunnyvale, United States. It is registered at Sunnyvale, California, United States.
Theron Pharma is a funded company, having raised a total of $2.21M across 6 funding rounds to date. The company's 1st funding round was a Seed of $180K, raised on May 2009.
Theron Pharma was founded in 2008 in Sunnyvale, United States, within the pharmaceutical sector. Long-acting M3 muscarinic antagonists are developed for treating chronic obstructive pulmonary disease and severe asthma. Focus is placed on a once-daily inhaled bronchodilator with properties enabling use across dry powder inhalers, metered-dose inhalers, and nebulizers, alongside compatibility for multi-drug formulations. Operations center on drug development for respiratory conditions.
Theron Pharma's top competitors include Dren Bio, PureTech Health and Innoviva.
Theron Pharma has 1 investor. Key investors include HHS.
Theron Pharma operates through Theron Pharmaceuticals Inc.